SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

New University Agreement

26 May 2011 07:00

RNS Number : 3083H
Frontier IP Group plc
26 May 2011
Β 

ο»Ώ

Β 

AIM: FIPP

Β 

Frontier IP Group Plc

("Frontier IP" or "the Company")

Β 

IP Commercialisation Relationship with University of Plymouth

Β 

Frontier IP (AIM: FIPP), which specialises in the commercialisation of university intellectual property ("IP"),Β is pleased to announce that it has been selected as the University of Plymouth's ("the University") IP commercialisation strategic partner following a competitive tender process. The Company has entered into a 10-year IP commercialisation agreement with the University, with a mutual option to extend for a further 10 years.

Β 

Under the terms of the agreement, Frontier IP will assist the University in the commercialisation of its IP across all faculties. In return for its advisory services, Frontier IP will receive a share of the income from all new licences and a percentage of the equity in each new spin-out company. The University of Plymouth is Frontier IP's third university partner, in addition to the University of Dundee and Robert Gordon University, Aberdeen.

Β 

The University of Plymouth is ranked as one of the top 50 research universities in the UK and 80 per cent. of its research has been judged "of international repute" *. Β In particular, the University has a world-class reputation for its research in marine sciences (operating Europe's largest marine institute), medical sciences, computer science and informatics and environmental sciences. It has a well established reputation for fostering innovation and has sought to build strong links between its research activities and industry. An early focus for Frontier IP will be the University's plans for a Centre for Translational Bio-Medicine.

Β 

Neil Crabb, Frontier IP's Executive Chairman, commented,

Β 

"We are delighted to have signed this agreement with the University of Plymouth. The University has a reputation for excellence in its research and we believe that there are exciting opportunities to aid the commercial development of some very interesting research projects."

Β 

Professor Wendy Purcell, Vice-Chancellor of the University of Plymouth said,

Β 

"We are delighted to be working with Frontier IP who bring us additional expertise in commercialising intellectual property and access to funding. This strategic relationship will help us to harness fully our ability to commercialise our knowledge base and it will have a major impact on our partnership-led approach to grow the knowledge economy in the region and create jobs."

Β 

Β 

*according to the latest Research Assessment Exercise (published in 2008 and conducted by the Higher Education Funding Council for England, the Scottish Funding Council, the Higher Education Funding Council for Wales and the Department for Employment and Learning, Northern Ireland)

Β 

Β 

Β 

For further information please contact:

Β 

Frontier IP Group Plc

Neil Crabb, Executive Chairman

Β 

T: 0131 220 9491

Arbuthnot Securities Limited

Tom Griffiths

Ed Groome

Β 

T: 020 7012 2000

Biddicks

Katie Tzouliadis

Sophie Lane

T: 020 3178 6378

Β 

About Frontier IP Group plc

www.frontierip.co.uk

Β 

Frontier IP specialises in the commercialisation of the intellectual property developed by universities and research institutions. It establishes partnerships with individual universities and research institutions to assist with their spin-out and licensing activities, and helps maximise the commercial value of technologies emerging from their research programmes. Frontier IP is traded on the AIM market.

Β 

About the University of Plymouth

www.plymouth.ac.uk

Β 

The University of Plymouth is ranked as one of the top modern universities in the UK, with a strong record of excellence, enterprise and innovation across its teaching and research activities.

Β 

With around 30,000 students in total, the University is also one of the largest in the UK. It is ranked in the top 50 research universities in the UK (Source: Research Fortnight league tables) and has four government-funded Centres for Excellence in Teaching & Learning, the maximum awarded to any single institution in the UK. The results of the Research Assessment Exercise 2008 showed the majority of areas submitted by the University included world-leading research, achieving the highest rating possible, scoring 4 stars. Overall, 80% of the research was judged as being of international repute.

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGRUVVNRARAVUAR
Date   Source Headline
26th May 20267:00 amRNS-RPortfolio news: Dekiln strategic partnership
5th May 20267:00 amRNSAppointment of Chief Financial Officer
16th Apr 20264:07 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSPortfolio News: 2D Photonics subsidiary grant
13th Apr 20262:35 pmRNSHolding(s) in Company
10th Apr 202610:30 amRNSUpdate re Investee Company
8th Apr 20267:00 amRNS-RPortfolio news – Fieldwork Robotics £3M fundraise
31st Mar 20265:18 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSUnaudited Half Year Results
23rd Mar 20267:00 amRNS-RAlusid reaches milestone in European roll out
28th Jan 20264:28 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RPortfolio news - Strong results for TVG vaccine
12th Jan 202610:30 amRNSHolding(s) in Company
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 20251:00 pmRNSTotal Voting Rights
31st Dec 202512:30 pmRNSResult of AGM
31st Dec 202512:30 pmRNSResult of AGM
29th Dec 20252:37 pmRNSHolding(s) in Company
29th Dec 20252:37 pmRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20259:52 amRNSHolding(s) in Company
24th Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20252:17 pmRNSDirectors' Shareholdings
23rd Dec 20252:17 pmRNSDirectors’ Shareholdings
22nd Dec 20253:48 pmRNSResult of Retail Offer
22nd Dec 20253:48 pmRNSResult of Retail Offer
18th Dec 20259:15 amRNS-RDekiln benefits from £3 million funding
17th Dec 202511:54 amRNSResult of Placing and Subscription
17th Dec 20257:01 amRNSRetail Offer
17th Dec 20257:00 amRNSProposed Placing and Subscription to raise £870k
15th Dec 20257:00 amRNS-RPortfolio news- Alusid £500k pre-IPO funding round
10th Dec 20254:56 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSPosting of Annual Report & Notice of AGM
8th Dec 20257:00 amRNSFinal results for the year ended 30 June 2025
2nd Dec 20257:00 amRNS-RAlusid signs Swedish distribution agreement
6th Nov 20257:00 amRNSBord Change
3rd Nov 20257:00 amRNS-RTVG demonstrates success in animal trials
20th Oct 20257:00 amRNS-RAmprologix raises £740,000 in Pre-Series A round
25th Sep 20257:00 amRNSBoard Changes
24th Sep 20255:12 pmRNSHolding(s) in Company
13th Jun 20257:00 amRNSStrategic partnership for Cambridge innovation hub
10th Jun 20257:00 amRNS-RAlusid signs international distribution agreement
6th May 20257:00 amRNS-RTVG's vaccine candidate enters animal trials
16th Apr 20257:00 amRNS-RSyva signs option to license agreement with TVG
2nd Apr 20254:47 pmRNSDirector/PDMR Shareholding
31st Mar 20251:02 pmRNSDirector/PDMR Shareholding
26th Mar 20257:00 amRNSUnaudited Half Year Results
24th Mar 20257:00 amRNSCamGraphIC secures €25 million in Series A funding
18th Mar 20257:00 amRNS-RPulsiv wins PSMA’s Global Energy Efficiency Award
25th Feb 20257:00 amRNS-RGraphEnergyTech collaboration & Innovate UK grant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.